Standard BioTools

Update in progress

LAB (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Standard BioTools Inc. and its subsidiaries develop, manufacture, and sell instruments, consumables, and services for scientists and biomedical researchers to advance therapeutics across the Americas, Europe, the Middle East, Africa, and Asia Pacific. It operates in Proteomics and Genomics, offering SomaScan, CyTOF, Hyperion, and Biomark X9 platforms for research use. It serves academic, translational, clinical, and biotech customers, licenses Caltech, Harvard, and Caliper, and is headquartered in Boston.

Company score

Sentiment: 0.22; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.06; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.12; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive